Clinical Trials Logo

Clinical Trial Summary

The clinical diagnosis and treatment of lower limb bone defect is a difficult problem in orthopedics. The traditional treatment has the shortcomings of long treatment period, no weight bearing in the early stage of the limb, weak mechanical strength, many complications, and difficulty in repairing deformed and large segment bone defects around the joint. The Orthopedics Department of Peking University Third Hospital, the lead unit of this study, developed the TCBridge system based on three-dimensional (3D) printing technology in the early stage, which is the first approved 3D printing lower limb long bone defect repair system in China. The system can achieve personalized and accurate repair of lower limb bone defects, and ensure patients to carry out limb weight and functional exercise safely in the early stage after surgery. On this basis, this study will establish a multi-center clinical case cohort to achieve accurate comprehensive diagnosis and treatment of lower limb bone defects, benefiting patients and contributing to society.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06269354
Study type Observational [Patient Registry]
Source Peking University Third Hospital
Contact Bingchuan Liu, Doctor
Phone +86 18310188678
Email liubc@bjmu.edu.cn
Status Recruiting
Phase
Start date November 1, 2023
Completion date December 31, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT04520087 - Clinical and Radiographic Assessment After Surgical Treatment of Anterior Shoulder Dislocation N/A
Recruiting NCT04644536 - Retrospective Collection of Safety and Performance Data
Active, not recruiting NCT03103295 - 3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects Phase 1/Phase 2
Recruiting NCT04645186 - Calcium Phosphate Cement as Bone Void Filler